<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Lucia Zamorano, MD, PLC</title>
	<atom:link href="https://www.luciazamorano.com/tag/atrial-fibrillation-2/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.luciazamorano.com</link>
	<description>Brain &#38; Spine Surgery</description>
	<lastBuildDate>Mon, 05 Aug 2013 07:08:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>Treat atrial fibrillation AF to prevent stroke</title>
		<link>https://www.luciazamorano.com/treat-atrial-fibrillation-af-to-prevent-stroke/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Mon, 05 Aug 2013 07:08:07 +0000</pubDate>
				<category><![CDATA[Stroke]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<guid isPermaLink="false">http://www.brainandspinesurgerycenter.com/?p=282</guid>

					<description><![CDATA[PRADAXA 150 mg twice daily provided an additional 35% risk reduction of stroke/systemic embolism vs warfarin Superior reduction of ischemic and hemorrhagic stroke vs warfarin Similar rate of major bleeds‡ with PRADAXA vs warfarin PRADAXA is the ONLY anticoagulant to demonstrate superior reduction of ischemic stroke vs warfarin PRADAXA also demonstrated a lower rate of&#8230;&#160;<a class="more-link" href="https://www.luciazamorano.com/treat-atrial-fibrillation-af-to-prevent-stroke/" rel="nofollow">[Continue Reading]</a>]]></description>
										<content:encoded><![CDATA[<p><a href="http://www.brainandspinesurgerycenter.com/wp-content/uploads/2013/08/pradaxa-stroke.jpg"><img decoding="async" class="alignright size-thumbnail wp-image-283" alt="pradaxa" src="http://www.brainandspinesurgerycenter.com/wp-content/uploads/2013/08/pradaxa-stroke-150x150.jpg" width="150" height="150" /></a>PRADAXA 150 mg twice daily provided an additional 35% risk reduction of stroke/systemic embolism vs warfarin</p>
<ul>
<li>Superior reduction of ischemic and hemorrhagic stroke vs warfarin</li>
<li>Similar rate of major bleeds<sup>‡</sup> with PRADAXA vs warfarin</li>
<li>PRADAXA is the ONLY anticoagulant to demonstrate superior reduction of ischemic stroke vs warfarin</li>
<li>PRADAXA also demonstrated a lower rate of intracranial bleeding vs warfarin</li>
</ul>
<p>Additional 35% risk reduction of stroke/systemic embolism vs warfarin. Protect the brain by reducing the risk of ischemic stroke.</p>
<p>Learn more at <a href="http://www.pradaxapro.com/" target="_blank">pradaxapro.com</a></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
